"Immune Sera" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.
| Descriptor ID |
D007106
|
| MeSH Number(s) |
A12.207.152.846.500 D12.776.124.486.485.114.573 D12.776.124.790.651.114.573 D12.776.377.715.548.114.573 D20.215.401
|
| Concept/Terms |
Immune Sera- Immune Sera
- Sera, Immune
- Antisera
- Immune Serums
- Serums, Immune
|
Below are MeSH descriptors whose meaning is more general than "Immune Sera".
Below are MeSH descriptors whose meaning is more specific than "Immune Sera".
This graph shows the total number of publications written about "Immune Sera" by people in this website by year, and whether "Immune Sera" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 4 | 5 |
| 2005 | 3 | 1 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 11 | 13 |
| 2019 | 1 | 2 | 3 |
| 2020 | 3 | 14 | 17 |
| 2021 | 2 | 12 | 14 |
To return to the timeline, click here.
Below are the most recent publications written about "Immune Sera" by people in Profiles.
-
History repeats itself: horse originated hyperimmune sera production against SARS CoV-2 Turk J Med Sci. 2021 10 21; 51(5):2263-2273.
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view. Biochim Biophys Acta Gen Subj. 2021 11; 1865(11):129974.
-
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C. Signal Transduct Target Ther. 2021 07 27; 6(1):285.
-
Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay. PLoS One. 2021; 16(7):e0253551.
-
Unified platform for genetic and serological detection of COVID-19 with single-molecule technology. PLoS One. 2021; 16(7):e0255096.
-
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants. Nat Commun. 2021 07 26; 12(1):4598.
-
How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
-
Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics. Front Immunol. 2021; 12:650465.
-
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv. 2021 05; 7(22).